Medtronic Expands US Robotic Surgery Footprint With New FDA General Surgery Approval
The FDA cleared Medtronic's Hugo robotic-assisted surgery system for general surgery, expanding access to 3.5 million annual U.S. cases.
Follow the latest Medtronic plc (MDT) news and market headlines alongside the live MDT price. Stay informed on what's moving MDT.
The FDA cleared Medtronic's Hugo robotic-assisted surgery system for general surgery, expanding access to 3.5 million annual U.S. cases.
The global nerve repair and regeneration market is projected to grow from USD 10.65 billion in 2025 to USD 20.97 billion by 2031, expanding at an 11.96% CAGR. Growth is driven by rising nerve injuries, advances in neurostimulation technologies, and biomaterial innovations. Neurostimulation devices currently dominate with 58.74% market share, while biomaterials are the fastest-growing segment at 14.01% CAGR. High implant costs and cybersecurity risks remain challenges, with Asia-Pacific expected to record the fastest regional growth.
Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.
Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.
Medtronic plans to acquire Contego Medical for $380 million, expanding its carotid artery and peripheral vascular device portfolio.
The article recommends five dividend stocks suitable for long-term buy-and-hold investors: Johnson & Johnson, Medtronic, Procter & Gamble, Federal Realty Investment Trust, and Realty Income. All five companies have strong dividend track records with at least 32 years of consecutive annual increases, combined with well-run underlying businesses that generate reliable income streams.
MacroGenics reported a quarterly loss of $0.34 per share, significantly worse than the consensus estimate of $0.10 loss, representing a -240% earnings surprise. Revenue also missed expectations at $18.67 million versus consensus, down 74% year-over-year. The stock holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions ahead.
The global Transcatheter Aortic Valve Replacement (TAVR) market is projected to grow from US$ 8.41 billion in 2025 to US$ 30.01 billion by 2035, driven by increasing prevalence of aortic stenosis, aging populations, and rising adoption of minimally invasive cardiac procedures. Technological advancements in valve platforms and delivery systems are creating growth opportunities, with Asia Pacific emerging as the fastest-growing region.
Abbott (ABT) announced FDA and CE Mark approvals for its UltiSynq defibrillation lead, which delivers both pacing and defibrillation therapy. The ASCEND CSP IDE trial demonstrated a 98.5% successful implantation rate, 97.5% complication-free rate, and 100% successful defibrillation in 120 tested patients. The device received FDA breakthrough designation. Competitors Medtronic and Boston Scientific also reported positive clinical results for their respective cardiac devices.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to MDT, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.